April 25, 2022 - Cancer risk stratification company PreciseDx, a Mount Sinai Health System spin-off, has developed artificial intelligence-enabled digital ...
Scientists develop artificial intelligence method to predict anti-cancer immunity
by UT Southwestern Medical Center
Activation of T cell immune response with the ...